Authors: BETTICHER DC RATSCHILLER D SCHMITZ SFH VONROHR A HESS U ZULIAN G WERNLI M TICHELLI A TOBLER A FEY MF CERNY T

Citation: Dc. Betticher et al., REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 9(7), 1998, pp. 721-726

Authors: BETTICHER DC VONROHR A RATSCHILLER D SCHMITZ SFH EGGER T SONDEREGGER T HERRMANN R KRONER T ZULIAN GB CAVALLI F FEY MF CERNY T

Citation: Dc. Betticher et al., FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(3), 1998, pp. 850-858

Authors: SPERB RA VONROHR A RATSCHILLER D BACCHI M TICHELLI A HESS U CERNY T TOBLER A BETTICHER DC

Citation: Ra. Sperb et al., 2-CDA IN THE TREATMENT OF HAIRY-CELL LEUKEMIA - INTRAVENOUS VS SUBCUTANEOUS ADMINISTRATION, Schweizerische medizinische Wochenschrift, 128(42), 1998, pp. 1593-1597

Authors: BETTICHER DC SCHMITZ SFH RATSCHILLER D VONROHR A EGGER T PUGIN P STALDER M HESS U FEY MF CERNY T

Citation: Dc. Betticher et al., CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA, British Journal of Haematology, 99(2), 1997, pp. 358-363